| 000 | 00945 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515010032.0 | ||
| 264 | 0 | _c20060131 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0364-5134 | ||
| 024 | 7 |
_a10.1002/ana.20696 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWüllner, Ullrich | |
| 245 | 0 | 0 |
_aMethylenetetrahydrofolate reductase in Parkinson's disease. _h[electronic resource] |
| 260 |
_bAnnals of neurology _cDec 2005 |
||
| 300 |
_a972-3 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethylenetetrahydrofolate Reductase (NADPH2) _xgenetics |
| 650 | 0 | 4 |
_aParkinson Disease _xepidemiology |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aKölsch, Heike | |
| 700 | 1 | _aLinnebank, Michael | |
| 773 | 0 |
_tAnnals of neurology _gvol. 58 _gno. 6 _gp. 972-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ana.20696 _zAvailable from publisher's website |
| 999 |
_c15937954 _d15937954 |
||